#738 Omnipod 5 Pro Tip: Connectivity

FDA Approval

The Omnipod 5 system is currently undergoing FDA approval processes for younger age groups. Scott Benner shares that Omnipod has submitted data for children as young as two years old, aiming to expand its usage to younger patients. Cari Berget expresses her appreciation for the opportunity to discuss these developments, highlighting the importance of making the system accessible to a broader age range 1.

I have one last thing here, and then I'm going to let you go. So the question is, is there any idea when the FDA will approve? For under six years old, this person says they're getting pushed back from their endo because their son is three and a half. Now, the answer from Omnipod is they've recently published data for that age group and that they've submitted to the FDA for an indication, all the way down to two.

--- Scott Benner

This step is crucial for families seeking advanced diabetes management solutions for their young children.

   

Software Updates

Omnipod is actively working on software updates and app developments to enhance user experience. Scott Benner confirms that a follow-up app, known as Omnipod View, is in progress, although no specific timeline is available. Cari Berget acknowledges the ongoing efforts to improve the system, emphasizing the dedication of the Omnipod team 2.

So is Omnipod working on a follow up? Yes, they are. Is there any indication of when the iOS app is coming? There's no timeline, but it is being worked on.

--- Scott Benner

These advancements aim to provide users with more efficient tools for diabetes management, ensuring that the Omnipod system remains at the forefront of technology.